Worth reading
52Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
290
¥ million (operating profit plan for the fiscal year ending March 2029)Wording
Avoiding a definitive answer
How definitive the wording is.Items stated in the management plan
FormulatedNet Sales+30.6%
基準 2,419Target3,160million
Operating profit+0.1%
基準 2,026Target2,029million
Operating profit margin+3.0pt
基準 2,026Target2,029%
Each line is the climb from the baseline the document states to the target it sets. The slope is scaled against the largest climb in this document. For metrics expressed as percentages, differences are shown in percentage points (pt).The increase shown by the dotted line is calculated from the two reported figures because the company did not provide the amount of growth.
Net income for the current fiscal yearFiscal year ending March 2026 (actual) -241 → Not disclosed
Only the target level is shown because the current level for comparison was not provided.What happened to the previous planFull-year forecast for the fiscal year ending March 2026 (revised on 10 February 2026): revenue 2,450, operating profit -141, ordinary loss -180, net income attributable to owners of the parent -186 → Full-year actual results for the fiscal year ending March 2026: revenue 2,419, operating profit -123, ordinary loss -160, net income attributable to owners of the parent -241-1.3%Calculated from the two disclosed figures
Key initiatives
01Strengthen support for existing customers
02Standardize operations supporting clinics that have introduced IFMC.
03Test sales in the D2C field
04Test AI consulting
05Expand market share in the Tokyo-Nagoya-Osaka region and regional hub cities, primarily through group clinics
06Expand the development of group clinics into regional cities
07Establish D2C and collaboration and royalty businesses
08Develop new offerings
Plan assumptionsWhile revenue from insurance income and out-of-pocket treatments is trending downward against a backdrop of population decline and other factors, the company expects the overall market to continue growing through the expansion of merchandise sales and other factors., Revenue for the fiscal year ending March 2027 is expected to increase by approximately 8% year on year.
Size of the Target MarketMarket Market of group clinics with 10 or more clinics that transact with the company / Scale ¥19.0 billion / Additional information Approximately 2,000 clinics, Market Market of group clinics with 10 or more clinics that do not transact with the company / Scale ¥82.0 billion / Additional information Approximately 7,000 clinics, Market Judo therapy clinic market / Scale ¥479.0 billion / Additional information Approximately 51,000 clinics, Market Self-care health equipment market / Scale ¥219.0 billion / Source Yano Research Institute, "2019 Market Reality and Future Outlook for Self-Care Health Equipment", Market Bed linen and bedding retail market / Scale ¥683.0 billion / Source Yano Research Institute, "Home Fashion Brand 2017", Market Domestic shipment value of sporting goods / Scale ¥1.6734 trillion / Source Yano Research Institute, "2025 Survey of the Sporting Goods Market"
Risks identified by the company
Risk Legal revision / Applicable segment All businesses / Overview Changes in laws and regulations, including the introduction of new legal restrictions and the tightening of existing legal restrictions / Impact Small / Timing of occurrence Medium- to Long-Term Outlook
Risk Dependence on equipment suppliers / Applicable segment Wellness / Overview The company may become unable to procure equipment at appropriate prices and times due to natural disasters, distribution disruptions, supplier bankruptcies and other factors. / Impact Medium / Timing of occurrence Medium- to Long-Term Outlook
Risk Competition from other companies / Applicable segment All businesses / Overview Differentiation from competitors may become difficult, or competition may intensify due to new entrants. / Impact Small / Timing of occurrence Medium- to Long-Term Outlook
Risk IFMC. / Applicable segment Wellness / Overview Descriptions of the effects of using IFMC. products may violate laws and regulations and be determined to be illegal. / Impact Medium / Timing of occurrence Short term to medium to long term
| Item | Details |
|---|---|
| Plan name | Medium-Term Management Plan (Fiscal Years Ending March 2027 to March 2029) |
| Plan period | Fiscal years ending March 2027 to March 2029 |
| Progress against the plan | Formulated |
| Sales Target | Fiscal year ending March 2026 (actual) 2,419 → Fiscal year ending March 2029 (plan) 3,160 |
| Operating profit target | Fiscal year ending March 2026 (actual) -123 → Fiscal year ending March 2029 (plan) 290 |
| Operating profit margin target | Fiscal year ending March 2026 (actual) - → Fiscal year ending March 2029 (plan) 9.2% |
| Net income target | Fiscal year ending March 2026 (actual) -241 → Not disclosed |
| Plan assumptions | While revenue from insurance income and out-of-pocket treatments is trending downward against a backdrop of population decline and other factors, the company expects the overall market to continue growing through the expansion of merchandise sales and other factors., Revenue for the fiscal year ending March 2027 is expected to increase by approximately 8% year on year. |
| Key initiatives | Strengthen support for existing customers, Standardize operations supporting clinics that have introduced IFMC., Test sales in the D2C field, Test AI consulting, Expand market share in the Tokyo-Nagoya-Osaka region and regional hub cities, primarily through group clinics, Expand the development of group clinics into regional cities, Establish D2C and collaboration and royalty businesses, Develop new offerings |
| Results under the previous plan | Full-year forecast for the fiscal year ending March 2026 (revised on 10 February 2026): revenue 2,450, operating profit -141, ordinary loss -180, net income attributable to owners of the parent -186 → Full-year actual results for the fiscal year ending March 2026: revenue 2,419, operating profit -123, ordinary loss -160, net income attributable to owners of the parent -241 |
| Size of the Target Market | Market Market of group clinics with 10 or more clinics that transact with the company / Scale ¥19.0 billion / Additional information Approximately 2,000 clinics, Market Market of group clinics with 10 or more clinics that do not transact with the company / Scale ¥82.0 billion / Additional information Approximately 7,000 clinics, Market Judo therapy clinic market / Scale ¥479.0 billion / Additional information Approximately 51,000 clinics, Market Self-care health equipment market / Scale ¥219.0 billion / Source Yano Research Institute, "2019 Market Reality and Future Outlook for Self-Care Health Equipment", Market Bed linen and bedding retail market / Scale ¥683.0 billion / Source Yano Research Institute, "Home Fashion Brand 2017", Market Domestic shipment value of sporting goods / Scale ¥1.6734 trillion / Source Yano Research Institute, "2025 Survey of the Sporting Goods Market" |
| Risks identified | Risk Legal revision / Applicable segment All businesses / Overview Changes in laws and regulations, including the introduction of new legal restrictions and the tightening of existing legal restrictions / Impact Small / Timing of occurrence Medium- to Long-Term Outlook, Risk Dependence on equipment suppliers / Applicable segment Wellness / Overview The company may become unable to procure equipment at appropriate prices and times due to natural disasters, distribution disruptions, supplier bankruptcies and other factors. / Impact Medium / Timing of occurrence Medium- to Long-Term Outlook, Risk Competition from other companies / Applicable segment All businesses / Overview Differentiation from competitors may become difficult, or competition may intensify due to new entrants. / Impact Small / Timing of occurrence Medium- to Long-Term Outlook, Risk IFMC. / Applicable segment Wellness / Overview Descriptions of the effects of using IFMC. products may violate laws and regulations and be determined to be illegal. / Impact Medium / Timing of occurrence Short term to medium to long term |
| Publication date | June 2026 |
Items this document does not state (12)
ROE targetROIC targetPayout ratio / DOE policyTreasury share acquisition policyCost of capitalSelf-assessment of PBR and share priceTotal investment planInvestment amount by sectorSegment targetNon-financial targetsReason for revision or withdrawalDate of board resolution
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company aims to increase revenue in response to the improvement in profitability that began in the fourth quarter of the fiscal year ending March 2026, continue structural reforms including a fundamental review of selling, general and administrative expenses, and concentrate resources on highly profitable businesses. It also cites confirmation that a recovery in IFMC.-related revenue is directly linked to improved profitability in the wellness business.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.